China Biopharma plant leak infects thousands with bacterial disease

▴ China Biopharma plant leak infects thousands with bacterial disease
Chinese authorities found a biopharmaceutical plant had used expired disinfectant in its production of Brucella vaccines for animals between July and August last year

Thousands of people in northwest China have tested positive for a bacterial disease after a leak from a state-owned biopharmaceutical plant making animal vaccines last year.

Health officials in Lanzhou city said 3,245 people had contracted brucellosis, a disease often caused by close contact with infected animals or animal products that can bring about fevers, joint pain, and headaches.

Another 1,401 people tested as an early positive for the disease, and health authorities said there was no evidence of person-to-person transmission so far.

Chinese authorities found a biopharmaceutical plant had used expired disinfectant in its production of Brucella vaccines for animals between July and August last year -- meaning the bacteria was not eradicated in its factory exhaust.

Contaminated gas from the China Animal Husbandry Lanzhou Biopharmaceutical Factory in Lanzhou formed aerosols containing the bacteria, and this was then carried by wind to the Lanzhou Veterinary Research Institute, infecting nearly 200 people there as of December last year.

More than 20 students and faculty members of Lanzhou University, some of whom had been to the institute, subsequently tested positive as well, according to Xinhua news agency.

Lanzhou's health commission said Friday that sheep, cattle, and pigs were most commonly involved in the spread of the bacteria.

According to the US Centers for Disease Control and Prevention, person-to-person transmission of brucellosis is "extremely rare" but some symptoms may reoccur or never go away.

These include recurrent fevers, chronic fatigue, swelling of the heart, or arthritis.

The factory -- which apologized earlier this year -- has had its brucellosis vaccine production license revoked, Lanzhou authorities said.

Compensation for patients would start in batches from October, according to local authorities.

Tags : #China #Biopharma #Bacteria #Disease #Infects #Leak

Related Stories

Loading Please wait...
-Advertisements-

Trending Now

China ropes in more countries for its COVID-19 vaccine trialsSeptember 29, 2020
Antarctica is still free of Covid-19. Can it stay that way?September 29, 2020
Over 200 travellers from India barred from Dubai flight over invalid Covid-19 testsSeptember 29, 2020
Netherland focuses on more stricker rule to comabt COVID-19 September 29, 2020
WHO aims to provide 120 Million rapid Coronavirus tests for poorer statesSeptember 29, 2020
UN chief on 1 Million COVID-19 deathsSeptember 29, 2020
Bahrain reports 585 Covid-19 cases, 777 recoveriesSeptember 28, 2020
Bringing hepatitis C testing and treatment to underserved communities in MadridSeptember 28, 2020
Polish doctor recovers from severe COVID-19 through rehabilitationSeptember 28, 2020
WHO supports rehabilitation of COVID-19 and other patients in UkraineSeptember 28, 2020
WHO work with migrant camps in Greece September 28, 2020
US employers being sued for COVID-19 infection spread September 28, 2020
Global Coronavirus deaths cross 1 Million markSeptember 28, 2020
Highly effective antibodies identified, may lead to passive COVID-19 vaccineSeptember 26, 2020
Europe has a lot of work to do to prevent COVID-19 transmission :WHOSeptember 26, 2020
Two million Coronavirus deaths : WHO September 26, 2020
Johnson & Johnson COVID-19 vaccine produces strong results September 26, 2020
New York to permanently switch to outdoor dining amid pandemicSeptember 26, 2020
WHO gave blessing for Coronavirus vaccine emergency use programme: ChinaSeptember 26, 2020
US surpasses 7 Million Coronavirus casesSeptember 26, 2020